bluebird bio $BLUE Announces 1-for-20 Reverse Stock Splithttps://www.businesswire.com/news/home/20241204905459/en/bluebird-bio-Announces-1-for-20-Reverse-Stock-Split
$BLUE is slowly making progress againCMS enters agreement with Vertex ($VRTX (+1,35 %) ), bluebird to improve access to gene therapieshttps://www.reuters.com/business/healthcare-pharmaceuticals/cms-enters-agreement-with-vertex-bluebird-improve-access-gene-therapies-2024-12-04/
